Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants

By sjmartinez • October 23, 2023

Mozaffari E, Chandak A, Gottlieb RL, Chima-Melton C, Read SH, Lee E, Der-Torossian C, Gupta R, Berry M, Hollemeersch S, Kalil AC. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants. Open Forum Infect Dis. 2023 Sep 22;10(10):ofad482. doi: 10.1093/ofid/ofad482. PMID: 37869410; PMCID: PMC10588622.

Tags: comparative effectiveness research, covid-19, Hospitalization, mortality, Publications, Pulmonary, Critical Care & Sleep Medicine, remdesivir

Related Posts

Neutrophil Transcriptomic Changes in Severe Sterile Vasoplegic Syndrome Resemble a Distinct Molecular Subtype of Septic Shock

Siletz AE, Kelly-Scumpia KM, Scumpia PO, Street K, Ragkousis V, Shirazi R, Sanaiha Y, Do TH, Shemin R, Kwon M, Crager S, Benharash P, Cryer[...]

Catheter Ablation for Supraventricular Tachyarrhythmias in Adults With Total Cavopulmonary Connection Fontan Palliation

Kamp AN, Moore JP, Alvarado C, Shay V, Ceresnak SR, Bessiere F, Hale B, LaPage MJ, Chang PM, Pilcher TA, Kilinc O, Al-Mousily M, von[...]

Kawasaki Disease in Adults: A Call to Action to Manage Lifelong Coronary Risk

Burns JC, Budoff MJ, Gluckman TJ, Mehran R, Brindis RG, O'Gara PT, Akagi T, Bhatt J, Gordon JB, Newburger JW. Kawasaki Disease in Adults: A[...]